Purpose of the ROMA Score
- To assess the risk of ovarian cancer in women with pelvic masses.
- To assist surgeons in determining the appropriate level of care and surgical approach.
- To provide higher sensitivity and specificity than CA-125 alone.
Book ROMA Score Test in Saudi Arabia | Lahalak Medical Platform
The ROMA score combines HE4 and CA125 levels to effectively estimate the likelihood of malignancy in women with pelvic masses, guiding critical surgical and clinical management decisions for better health.
Scientific name: Risk of Ovarian Malignancy Algorithm (ROMA Score)
A specialized serum test combining HE4 and CA125 markers. It calculates a risk score to determine the likelihood of ovarian cancer in women diagnosed with pelvic masses.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Cancer Antigen 125 (CA-125) Test
- Human Epididymis Protein 4 (HE4) Test
- ROMA Algorithm Calculation
Medical Service Information
Who Should Get This Test?
- Women diagnosed with a pelvic or ovarian mass via imaging.
- Patients scheduled for pelvic surgery to evaluate malignancy risk.
- Women needing precise monitoring of ovarian health pre- or post-menopause.
Frequently Asked Questions
- Is this a definitive diagnosis? No, it is a risk assessment tool to guide clinical decisions.
- How fast are results? Results are typically available within 24 to 48 hours.
Conditions & Notices
- Must inform the lab of menopausal status
- Preferred to be performed before any surgical intervention
Medical services you might also like
